Research
Ultime pubblicazioni:
-
Di Giacomo, A.M., Lahn, M., Eggermont, A.M., Fox, B., Ibrahim, R., Sharma, P., et al. (2024). The future of targeting cytotoxic T-lymphocyte-associated protein-4: Is there a role?. EUROPEAN JOURNAL OF CANCER, 198 [10.1016/j.ejca.2023.113501]. - view more
-
Necchi, A., Pouessel, D., Leibowitz, R., Gupta, S., Fléchon, A., García-Donas, J., et al. (2024). Pemigatinib for metastatic or surgically unresectable urothelial carcinoma with FGF/FGFR genomic alterations: final results from FIGHT-201. ANNALS OF ONCOLOGY, 35(2), 200-210 [10.1016/j.annonc.2023.10.794]. - view more
-
Valente, M., Colucci, M., Vegni, V., Croce, V., Bellan, C., Rossi, G., et al. (2024). A Multidisciplinary Approach to Improve the Management of Immune-Checkpoint Inhibitor-Related Pneumonitis. ONCOTARGETS AND THERAPY, 17, 673-681 [10.2147/OTT.S470892]. - view more
-
Lofiego, M.F., Piazzini, F., Caruso, F.P., Marzani, F., Solmonese, L., Bello, E., et al. (2024). Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches. JOURNAL OF TRANSLATIONAL MEDICINE, 22(1) [10.1186/s12967-024-05040-x]. - view more
-
Splendiani, E., Besharat, Z.M., Covre, A., Maio, M., Di Giacomo, A.M., Ferretti, E. (2024). Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers?. PHARMACOLOGY & THERAPEUTICS, 256 [10.1016/j.pharmthera.2024.108613]. - view more
